Study Stopped
Terms for legal agreements between institution and Sponsor could not be made.
Assessment of Hemodynamic Changes During Weaning From Mechanical Ventilation With Flo-Trac Vigileo (TM) Monitor.
Use of Flo-Trac/Vigileo (TM) for Hemodynamic Monitoring During Discontinuation From Mechanical Ventilation
1 other identifier
observational
N/A
1 country
1
Brief Summary
Failure to wean from mechanical ventilation (failure to get the patients off the breathing machine) is associated with prolonged stay in the intensive care unit and increased risk of death. Some patients have difficulty successfully getting off the ventilator and breathing on their own. Usually this difficulty is due to lung problems. But sometimes it is due to heart problems, or heart failure. To improve a patient's chances of successfully getting off the ventilator early, it is helpful to the doctors to know if patient has heart failure and to measure how severe. With the new monitoring system being studied here, doctors may be able to detect and measure heart failure more easily. A new monitor (Vigileo TM) that is connected with a specific cable (Flo-TracTM) to a catheter that is inside the patient's artery (arterial line) has lately been developed. This monitor can estimate the amount of blood that the heart is pumping per minute, known as cardiac output. The heart is supposed to pump blood harder when a patient is being weaned from the breathing machine. With the above mentioned monitor, we hope to detect those patients whose hearts are weak and are not pumping as hard as they should.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 22, 2008
CompletedFirst Posted
Study publicly available on registry
March 10, 2008
CompletedNovember 5, 2020
November 1, 2020
Same day
February 22, 2008
November 3, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
To describe the hemodynamic changes during the process of discontinuation from mechanical ventilation with the aid of Flo-Trac/Vigileo (TM)
2 and 9 months
Secondary Outcomes (2)
To compare the hemodynamic changes between patients who had successful and those who had unsuccessful discontinuation from mechanical ventilation
2 and 9 months
To determine if the lack of increase in cardiac output during discontinuation from mechanical ventilation is associated with and predictive of weaning failure
2 and 9 months
Study Arms (1)
MICU-1
Mechanically ventilated patients who are about to start a weaning trial at the medical intensive care unit of Memorial Hermann Hospital.
Eligibility Criteria
Mechanically ventilated patients at Memorial Hermann Hospital MICU.
You may qualify if:
- Age 18 years or older
- Arterial line in place
- Normal sinus rhythm by electrocardiographic monitoring
- Mechanical ventilation for at least 24 hours
- Ventilation via oral or nasal endotracheal tube
- Patient meets the following weaning criteria before starting weaning protocol:
- PaO2/FiO2 ratio \>200
- FiO2 equal or less than 50%
- Positive end-expiratory pressure (PEEP) 5cm H20 or less
- Respiratory frequency/Tidal volume ratio less 105
- Respiratory rate \< 30 breaths/min
- Presence of cough and gag reflex
- hours free from sedation (opioids/benzodiazepine)
- hours free from sedation in case patient is on Propofol
- Systolic blood pressure above 90 mmHg and below 180 mmHg
- +1 more criteria
You may not qualify if:
- Known neurological disorder that might impair ventilatory drive
- Known neuromuscular disease
- Inotropic or vasopressor infusion
- Cardiac pacemaker
- Terminal condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Hermann Hospital
Houston, Texas, 77030, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Roberto F Casal, MD
The University of Texas Health Science Center, Houston
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2008
First Posted
March 10, 2008
Study Start
February 1, 2008
Primary Completion
February 1, 2008
Study Completion
February 1, 2008
Last Updated
November 5, 2020
Record last verified: 2020-11